
Prognyx is an oncology competitive-intelligence service for clinical-stage biotechs.
This connector gives your AI three read-only tools over public data. compare_trials: up to three interventional ClinicalTrials.gov studies matching an asset or target and an oncology indication, side by side, with sponsor, phase, status, declared arms, primary outcomes, last registry update and the registry URL.
https://www.prognyx.com/api/mcpPrognyx gives source-linked oncology competitive intelligence. Use to set up to three registry studies around an asset or target in one indication side by side, for the wider trial landscape of a target, company, indication or NCT number, and for Prognyx analyses of recent oncology events. Every study carries its ClinicalTrials.gov URL; cite it. Only public research terms are accepted: never send confidential programme names or personal data.
None in the store listings or on the server